Mounjaro to be covered by Gesy for diabetes and adult obesity

The anti-obesity drug Mounjaro will be covered by Gesy for Type II diabetes and obesity in adults from Thursday, the health insurance organisation has announced. Coverage of tirzepatide, the drug’s active ingredient, will be subject to approved protocols. The revised protocol…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Cyprus Mail.